These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17352743)

  • 61. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.
    Coffinier C; Hudon SE; Farber EA; Chang SY; Hrycyna CA; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13432-7. PubMed ID: 17652517
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synergistic induction of the senescence-associated genes by 5-bromodeoxyuridine and AT-binding ligands in HeLa cells.
    Suzuki T; Michishita E; Ogino H; Fujii M; Ayusawa D
    Exp Cell Res; 2002 Jun; 276(2):174-84. PubMed ID: 12027447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunolocalization of detergent-susceptible nucleoplasmic lamin A/C foci by a novel monoclonal antibody.
    Muralikrishna B; Thanumalayan S; Jagatheesan G; Rangaraj N; Karande AA; Parnaik VK
    J Cell Biochem; 2004 Mar; 91(4):730-9. PubMed ID: 14991764
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term expression of the lamin A mutant associated with dilated cardiomyopathy induces senescence.
    Moriuchi T; Muraoka T; Mio K; Osumi T; Hirose F
    Genes Cells; 2014 Dec; 19(12):901-18. PubMed ID: 25319090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prelamin A processing and functional effects in restrictive dermopathy.
    Columbaro M; Mattioli E; Schena E; Capanni C; Cenni V; Levy N; Navarro CL; Del Coco R; Squarzoni S; Camozzi D; Hutchison CJ; Wehnert M; Lattanzi G
    Cell Cycle; 2010 Dec; 9(23):4766-8. PubMed ID: 21127399
    [No Abstract]   [Full Text] [Related]  

  • 66. Nuclear envelope.
    Dultz E; Ellenberg J
    Curr Biol; 2007 Mar; 17(5):R154-6. PubMed ID: 17339009
    [No Abstract]   [Full Text] [Related]  

  • 67. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
    Greenberg SA; Pinkus JL; Amato AA
    Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Medicine. Mouse study suggests cancer drugs could help prematurely aging kids.
    Travis J
    Science; 2006 Feb; 311(5763):934-5. PubMed ID: 16484462
    [No Abstract]   [Full Text] [Related]  

  • 69. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors.
    Rusiñol AE; Sinensky MS
    J Cell Sci; 2006 Aug; 119(Pt 16):3265-72. PubMed ID: 16899817
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Subcellular localization and partial purification of prelamin A endoprotease: an enzyme which catalyzes the conversion of farnesylated prelamin A to mature lamin A.
    Kilic F; Johnson DA; Sinensky M
    FEBS Lett; 1999 Apr; 450(1-2):61-5. PubMed ID: 10350058
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria.
    Fong LG; Frost D; Meta M; Qiao X; Yang SH; Coffinier C; Young SG
    Science; 2006 Mar; 311(5767):1621-3. PubMed ID: 16484451
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular tools that block maturation of the nuclear lamin A and decelerate cancer cell migration.
    Matralis AN; Xanthopoulos D; Huot G; Lopes-Paciencia S; Cole C; de Vries H; Ferbeyre G; Tsantrizos YS
    Bioorg Med Chem; 2018 Nov; 26(20):5547-5554. PubMed ID: 30309670
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prenylated prelamin A interacts with Narf, a novel nuclear protein.
    Barton RM; Worman HJ
    J Biol Chem; 1999 Oct; 274(42):30008-18. PubMed ID: 10514485
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prelamin A overexpression promotes detrusor calcification/aging in urinary incontinence via prelamin A accumulation.
    Wu J; Guan F; Luo W; Yuan ZW; Chen RQ; Gou X; Shi X; Guo HX; Fang KW
    J Cell Physiol; 2019 Aug; 234(10):17800-17811. PubMed ID: 30895608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced expression of lamin A/C results in modified cell signaling and metabolism coupled with changes in expression of structural proteins.
    Chen S; Martin C; Maya-Mendoza A; Tang CW; Lovrić J; Sims PF; Jackson DA
    J Proteome Res; 2009 Nov; 8(11):5196-211. PubMed ID: 19775189
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease.
    Kilic F; Dalton MB; Burrell SK; Mayer JP; Patterson SD; Sinensky M
    J Biol Chem; 1997 Feb; 272(8):5298-304. PubMed ID: 9030603
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Falling apart.
    Davenport RJ
    Sci Aging Knowledge Environ; 2005 Jun; 2005(26):nf52. PubMed ID: 15994212
    [No Abstract]   [Full Text] [Related]  

  • 78. Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer.
    Capo-chichi CD; Cai KQ; Smedberg J; Ganjei-Azar P; Godwin AK; Xu XX
    Chin J Cancer; 2011 Jun; 30(6):415-25. PubMed ID: 21627864
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of prelamin A endoprotease activity by prelamin A.
    Kilic F; Salas-Marco J; Garland J; Sinensky M
    FEBS Lett; 1997 Sep; 414(1):65-8. PubMed ID: 9305733
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lamin A/C and polymeric actin in genome organization.
    Ondrej V; Lukásová E; Krejcí J; Matula P; Kozubek S
    Mol Cells; 2008 Oct; 26(4):356-61. PubMed ID: 18612243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.